跳至主要内容
临床试验/NCT02821169
NCT02821169已完成3 期

Impact of Infiltration in the Region of the Palatine Ganglion Spheno by Ropivacaine on Postoperative Pain in the Setting of Endoscopic Sinonasal Surgery.

University Hospital, Lille1 个研究点 分布在 1 个国家目标入组 184 人开始时间: 2015年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
184
试验地点
1
主要终点
Visual analog scale

研究概览

简要总结

Endoscopic sinus surgery (ESS) is a prevalent surgical procedure. It is required in many chronic rhinosinusitis for whom the medical treatment failed. In order to improve the postoperative management of patients treated with ESS, we aim to assess the analgesic action of local injection of ropivacaine in the nasal fossa.

详细描述

A prospective randomized double blind placebo controlled study was designed. Local injection of ropivacaine or placebo was conducted at the end of the surgical procedure in both nasal fossa through endoscopic view in the sphenopalatine region.

Pain was measured in the postoperative course with visual analogic scale in the recovery room and the rhinologic department.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients requiring endoscopic sinus surgery
  • ASA score 1 or 2
  • patients with health care insurance
  • approved consent

排除标准

  • any sinonasal malignant tumor
  • renal failure, hepatic disorder, respiratory deficiency, cardiovascular diseases
  • neurologic disorders
  • alcohol or drugs addiction
  • preoperative facial pain from an extranasal origin
  • coagulation disorders
  • antidepressive treatment

研究组 & 干预措施

saline solution 0.9%

Placebo Comparator

injection of saline solution in the sphenopalatine area in both nasal fossa

干预措施: saline solution 0.9% (Drug)

ropivacaine (2mg/ml)

Active Comparator

injection of ropivacaine in the sphenopalatine area in both nasal fossa

干预措施: ropivacaine (Drug)

结局指标

主要结局

Visual analog scale

时间窗: at the 2 postoperative hours

Measure the intensity pain, in the group treated with Ropivacaine.

次要结局

  • Analgesics consumption orally(during the 7 days post-surgery)
  • Administration of analgesics by parenteral route(at the 2 postoperative hours)
  • Visual analog scale for the during postoperative pain(At Morning and evening between the 1 and 7 days post surgery)
  • Visual analog scale for the intensity postoperative pain(at the 4 and at the 6 postoperative hours)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验